Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Rivera

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Annals of Neurology|March 5, 2014
A novel mechanism for cyclic adenosine monophosphate-mediated memory formation: Role of amyloid betaRoberta Ricciarelli, Daniela Puzzo, Olga Bruno, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 20, 2017
Amyloid-β Peptide Is Needed for cGMP-Induced Long-Term Potentiation and MemoryAgostino Palmeri, Roberta Ricciarelli, Walter Gulisano, et al.
Journal of Clinical Medicine|December 9, 2023
The Advantages of Next-Generation Sequencing Molecular Classification in Endometrial Cancer DiagnosisDaniela Rivera, Michele Paudice, Giulia Accorsi, et al.
Frontiers in Immunology|September 26, 2022
Female offspring gestated in hypothyroxinemia and infected with human Metapneumovirus (hMPV) suffer a more severe infection and have a higher number of activated CD8<sup>+</sup> T lymphocytesSamanta C Funes, Mariana Ríos, Ayleen Fernández-Fierro, et al.
Immunology|September 12, 2019
Tolerogenic dendritic cell transfer ameliorates systemic lupus erythematosus in miceSamanta C Funes, Mariana Ríos, Felipe Gómez-Santander, et al.
Frontiers in Immunology|May 30, 2024
Immune responses during COVID-19 breakthrough cases in vaccinated children and adolescentsDaniela Rivera-Pérez, Constanza Méndez, Benjamín Diethelm-Varela, et al.
Frontiers in Immunology|October 18, 2021
Immune Profile and Clinical Outcome of Breakthrough Cases After Vaccination With an Inactivated SARS-CoV-2 VaccineLuisa F Duarte, Nicolás M S Gálvez, Carolina Iturriaga, et al.
Frontiers in Immunology|December 3, 2021
Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated VaccineFelipe Melo-González, Jorge A Soto, Liliana A González, et al.
Medrxiv : the Preprint Server for Health Sciences|April 20, 2022
A booster dose of an inactivated SARS-CoV-2 vaccine increases neutralizing antibodies and T cells that recognize Delta and Omicron variants of concernBárbara M Schultz, Felipe Melo-González, Luisa F Duarte, et al.
Ebiomedicine|April 26, 2023
Humoral and cellular response induced by a second booster of an inactivated SARS-CoV-2 vaccine in adultsConstanza Méndez, Hernán F Peñaloza, Bárbara M Schultz, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Annals of Neurology|March 5, 2014
A novel mechanism for cyclic adenosine monophosphate-mediated memory formation: Role of amyloid betaRoberta Ricciarelli, Daniela Puzzo, Olga Bruno, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 20, 2017
Amyloid-β Peptide Is Needed for cGMP-Induced Long-Term Potentiation and MemoryAgostino Palmeri, Roberta Ricciarelli, Walter Gulisano, et al.
Journal of Clinical Medicine|December 9, 2023
The Advantages of Next-Generation Sequencing Molecular Classification in Endometrial Cancer DiagnosisDaniela Rivera, Michele Paudice, Giulia Accorsi, et al.
Frontiers in Immunology|September 26, 2022
Female offspring gestated in hypothyroxinemia and infected with human Metapneumovirus (hMPV) suffer a more severe infection and have a higher number of activated CD8<sup>+</sup> T lymphocytesSamanta C Funes, Mariana Ríos, Ayleen Fernández-Fierro, et al.
Immunology|September 12, 2019
Tolerogenic dendritic cell transfer ameliorates systemic lupus erythematosus in miceSamanta C Funes, Mariana Ríos, Felipe Gómez-Santander, et al.
Frontiers in Immunology|May 30, 2024
Immune responses during COVID-19 breakthrough cases in vaccinated children and adolescentsDaniela Rivera-Pérez, Constanza Méndez, Benjamín Diethelm-Varela, et al.
Frontiers in Immunology|October 18, 2021
Immune Profile and Clinical Outcome of Breakthrough Cases After Vaccination With an Inactivated SARS-CoV-2 VaccineLuisa F Duarte, Nicolás M S Gálvez, Carolina Iturriaga, et al.
Frontiers in Immunology|December 3, 2021
Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated VaccineFelipe Melo-González, Jorge A Soto, Liliana A González, et al.
Medrxiv : the Preprint Server for Health Sciences|April 20, 2022
A booster dose of an inactivated SARS-CoV-2 vaccine increases neutralizing antibodies and T cells that recognize Delta and Omicron variants of concernBárbara M Schultz, Felipe Melo-González, Luisa F Duarte, et al.
Ebiomedicine|April 26, 2023
Humoral and cellular response induced by a second booster of an inactivated SARS-CoV-2 vaccine in adultsConstanza Méndez, Hernán F Peñaloza, Bárbara M Schultz, et al.
Pageof 4